Tuala, Shella Rose .
HRN: 24-21-00 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2025
CEFUROXIME 500MG (TAB)
07/10/2025
07/16/2025
PO
500mg
BID
S/p NSVD, UTI In Pregnancy
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes